GNS.L
Price:
$2045
Market Cap:
$1.34B
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agri...[Read more]
Industry
Biotechnology
IPO Date
2000-07-06
Stock Exchange
LSE
Ticker
GNS.L
According to Genus plc’s latest financial reports and current stock price. The company's current PE Ratio is 170.42. This represents a change of 2.02% compared to the average of 8.04 of the last 4 quarters.
The mean historical PE Ratio of Genus plc over the last ten years is 67.94. The current 170.42 PE Ratio has changed 24.98% with respect to the historical average. Over the past ten years (40 quarters), GNS.L's PE Ratio was at its highest in in the June 2018 quarter at 682.50. The PE Ratio was at its lowest in in the June 2024 quarter at -48.57.
Average
67.94
Median
41.37
Minimum
19.31
Maximum
213.87
Discovering the peaks and valleys of Genus plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 465.77%
Maximum Annual PE Ratio = 213.87
Minimum Annual Increase = -69.63%
Minimum Annual PE Ratio = 19.31
Year | PE Ratio | Change |
---|---|---|
2024 | 137.69 | 222.90% |
2023 | 42.64 | 6.34% |
2022 | 40.10 | -41.27% |
2021 | 68.27 | 5.13% |
2020 | 64.94 | -69.63% |
2019 | 213.87 | 465.77% |
2018 | 37.80 | 14.30% |
2017 | 33.07 | 71.32% |
2016 | 19.31 | -11.08% |
2015 | 21.71 | -9.72% |
The current PE Ratio of Genus plc (GNS.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
73.48
5-year avg
70.73
10-year avg
67.94
Genus plc’s PE Ratio is greater than Dechra Pharmaceuticals PLC (-157.77), greater than Cranswick plc (24.18), greater than Diploma PLC (49.65), greater than Spectris plc (9.12), greater than Grainger plc (-1536.67),
Company | PE Ratio | Market cap |
---|---|---|
-157.77 | $4.40B | |
24.18 | $2.72B | |
49.65 | $5.76B | |
9.12 | $2.44B | |
-1536.67 | $1.70B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genus plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genus plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genus plc's PE Ratio?
How is the PE Ratio calculated for Genus plc (GNS.L)?
What is the highest PE Ratio for Genus plc (GNS.L)?
What is the 3-year average PE Ratio for Genus plc (GNS.L)?
What is the 5-year average PE Ratio for Genus plc (GNS.L)?
How does the current PE Ratio for Genus plc (GNS.L) compare to its historical average?